Trojanowski and colleagues finds that Anti-Tau Drug Improves Cognition and Decreases Tau Tangles in Alzheimer's Disease Models and Drugmaker Begins Phase I Clinical Trial to Test Microtubule Stabilizing-Drug in Mild Alzheimer's Cases.
Trojanowski and colleagues finds that Anti-Tau Drug Improves Cognition and Decreases Tau Tangles in Alzheimer's Disease Models and Drugmaker Begins Phase I Clinical Trial to Test Microtubule Stabilizing-Drug in Mild Alzheimer's Cases.